ALKEM LABORATORIES SUBSIDIARY IN SAUDI ARABIA: PLANS NON-U.S. FOOTPRINT 

Date:

Share post:

ALKEM LABORATORIES SUBSIDIARY IN SAUDI ARABIA: PLANS NON-U.S. FOOTPRINT 

 

 

 

 

 

PharmaGenDRx News Bureau – 16th August, 2025

10:00 AM IST

 According to recent Press coverages, Alkem Laboratories Limited is strengthening its global presence by expanding beyond the United States market. Following which the company is reportedly set to incorporate a subsidiary in the Kingdom of Saudi Arabia. It has also been heard that the company will be  holding a 51% equity stake in partnership with a local Saudi firm.

The new plant aims to capture the Middle East’s fastest growing market and will focus on nutraceuticals along with pharmaceutical products.Media reports highlight that this move aligns with Alkem’s broader plan to diversify its international revenue streams and reduce dependence on the US market.

As per financial year reports Alkem continues to show a strong financial growth with about more than 600 Crore net profit. This new strategy will mark another milestone in Alkem’s global growth journey.

By Sharon Bose and Arundhuti Chatterjee 

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Dabur India Plant Under US FDA Scanner Over Contamination Concerns

The United States Food and Drug Administration (US FDA) has flagged serious concerns at Dabur India's manufacturing facility...

FDA Approves Wockhardt’s Novel Antibiotic ZAYNICH™️ for cUTI

Wockhardt Limited  announced that the U.S. Food and Drug Administration (FDA) has approved ZAYNICH™ (cefepimeand zidebactam), a novel intravenous antibiotic...

Relief for Patients: NPPA Fixes Ceiling Prices for 30 Essential Medicines

The National Pharmaceutical Pricing Authority (NPPA) has notified ceiling prices for 30 essential fixed-dose combination medicines under the...

FDA Draft Guidance Aims to Reduce Animal Testing for Cancer Drugs

The U.S. Food and Drug Administration (FDA) issued a new draft guidance aimed at reducing unnecessary animal testing...